Logo-jnp
J Nephropathol. 2020;9(3): e22. doi: 10.34172/jnp.2020.22

Review

Acute and delayed nephropathy due to methamphetamine abuse

Samad Godrati 1,2 ORCID, Aiyoub Pezeshgi 1,2 ORCID, Rohollah Valizadeh 3 ORCID, Steven James Kellner 4 ORCID, Seyed Ramin Radfar 5,6 ORCID

Cited by CrossRef: 5

1- Grace Choung H, Nast C, Haas M, Lin M, Yamashita M, Hou J. Spectrum of Kidney Biopsy Findings Associated With Methamphetamine Use. Kidney International Reports. 2024;9(7):2180 [Crossref]
2- Seyed Aliyan S, Roohbakhsh A, Jafari Fakhrabad M, Salmasi Z, Moshiri M, Shahbazi N, Etemad L. Evaluating the Protective Effects of Thymoquinone on Methamphetamine-induced Toxicity in an In Vitro Model Based on Differentiated PC12 Cells. Altern Lab Anim. 2024;52(2):94 [Crossref]
3- Stolić R, Milić M, Mitrović V, Karanović A, Bulatović K, Rašić D, Mirović M, Mitić B. The influence of psychoactive substances on nephrotoxicity of the kidneys. Acta fac medic Naissensis. 2024;41(2):162 [Crossref]
4- Sandy K, Rahmania T, Arfiyani E. Identification of Methamphetamine and Amphetamine in Drug Abuse Urine Sample using Multi-drug Rapid Test and Gas Chromatography- Mass Spectrometry (GC-MS) at the Centre of Drug Testing Laboratory, National Narcotics Board Republic of Indonesia. CPA. 2023;19(7):533 [Crossref]
5- Fakharbad M, Moshiri M, Ommati M, Talebi M, Etemad L. A review of basic to clinical studies of the association between hyperammonemia, methamphetamine. Naunyn-Schmiedeberg's Arch Pharmacol. 2022;395(8):921 [Crossref]